Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-15-002168)

Filing Details

Accession Number:: 0001493152-15-002168
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-05-20 16:18:29
Reporting Period:: 2015-05-18

Filing Date:: 2015-05-20
Accepted Time:: 2015-05-20 16:18:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1360214	Imprimis Pharmaceuticals Inc.	IMMY	Pharmaceutical Preparations (2834)	450567010

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1555960	Paul Donald Miloni	1425 Greenwood Lane Greenwood Village CO 80125		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-05-18	300,000	$8.00	578,576	No	4	S	Direct
Common Stock	Disposition	2015-05-19	110,000	$8.00	468,576	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	25,316	Indirect	By wife
Common Stock	151,898	Indirect	By 1425 Greenwood Lane, LLC
Common Stock	101,265	Indirect	By RCHER Financial, LLC

Footnotes

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.